— Know what they know.
Not Investment Advice
Also trades as: 4DX.AX (ASX) · $vol 17M

FDMDF Earnings

4DMedical Limited
1W: +9.1% 1M: +1.7% 3M: +7.1% YTD: +27.7% 1Y: +129.0% 3Y: +1251.3%
$3.00
+0.25 (+9.09%)
 
OTC · Healthcare · Medical - Devices · Tech Score Neutral · Power 60 · $1.8B mcap · 443M float · 0.0006% daily turnover · Short 88% of daily vol
Last Earnings 2026-08-28
EPS
A$0.16 (US$0.11)
▲ Beat +665.7%
Revenue
A$3M ($2M)
▼ Miss -44.6%

Estimate vs Actual

Earnings Surprise History

2/18
EPS Beats
0/18
Revenue Beats
11%
EPS Beat Rate
0%
Rev Beat Rate

Wall Street Forward Estimates

Quarterly
Annual

Estimate Revisions

Recent Revisions
DatePeriodFiscal DateEPS OldEPS NewChangeRev OldRev New
2026-10-02 annual 2028-06-30 A$-0.01 A$-0.01 — A$57,412,102 A$57,255,866
2026-10-02 annual 2029-06-30 A$0.04 A$0.04 — A$99,227,461 A$98,957,433
2026-10-02 annual 2027-06-30 A$-0.06 A$-0.06 — A$22,323,215 A$22,262,467
2026-10-01 annual 2028-06-30 A$-0.01 A$-0.01 — A$58,005,633 A$57,412,102
2026-10-01 annual 2029-06-30 A$0.04 A$0.04 — A$100,253,282 A$99,227,461
2026-10-01 annual 2027-06-30 A$-0.06 A$-0.06 — A$22,553,994 A$22,323,215
2026-09-29 annual 2027-06-30 A$-0.06 A$-0.06 — A$22,533,424 A$22,553,994
2026-09-29 annual 2028-06-30 A$-0.01 A$-0.01 — A$57,952,727 A$58,005,633
2026-09-29 annual 2029-06-30 A$0.04 A$0.04 — A$100,161,844 A$100,253,282
2026-09-28 annual 2027-06-30 A$-0.06 A$-0.06 — A$22,875,414 A$22,533,424
2026-09-28 annual 2028-06-30 A$-0.01 A$-0.01 — A$58,832,277 A$57,952,727
2026-09-28 annual 2029-06-30 A$0.05 A$0.04 ▼ 0.01 A$101,682,002 A$100,161,844
2026-09-22 annual 2027-06-30 A$-0.06 A$-0.06 — A$22,846,165 A$22,875,414
2026-09-22 annual 2029-06-30 A$0.05 A$0.05 — A$101,551,989 A$101,682,002
2026-09-22 annual 2028-06-30 A$-0.01 A$-0.01 — A$58,757,052 A$58,832,277
Earnings Call Transcripts
No transcripts available.

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms